article thumbnail

CPAP Or Zepbound? Patients, Doctors Debate Sleep Apnea Treatment

Drugs.com

MONDAY, June 9, 2025 — A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study reports. Doctors favor treatment with continuous positive airway pressure (CPAP) machines.

Doctors 232
article thumbnail

After surprise trial failure, ALS doctors brace for one less treatment option

BioPharma Drive: Drug Pricing

Physicians are preparing for tough conversations with patients on Amylyx Pharmaceuticals’ drug, Relyvrio, while holding out hope it still may help some with the disease.

Doctors 310
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

As ALS research booms, one treatment center finds itself in the spotlight

BioPharma Drive: Drug Pricing

The Healey center is at the front of ALS research and care, earning acclaim from patients, doctors and scientists. Still, the complexities of the disease and of drug development have brought hard-felt losses.

Research 356
article thumbnail

More U.S. Teens Are Now Taking Wegovy for Weight Loss

Drugs.com

THURSDAY, June 5, 2025 — More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment. But experts say access is still limited, and more research on its long-term safety in.

Doctors 234
article thumbnail

Eating more fruits and vegetables to reduce dietary acid lowers blood pressure and improves kidney and heart health in patients with hypertension

Science Daily: Pharmacology News

Doctors recommend making fruits and vegetables a foundational part of the treatment of patients with hypertension. Diets high in fruits and vegetables are found to lower blood pressure, reduce cardiovascular risk, and improve kidney health due to their base-producing effects.

Doctors 338
article thumbnail

Madrigal, FDA approval in hand, outlines plan to sell MASH drug

BioPharma Drive: Drug Pricing

The company expects initial uptake of Rezdiffra, which costs $47,400 per year, to be slow as doctors and insurers establish the protocols needed to find patients eligible for treatment.

article thumbnail

AHA News: What Is Shared Decision-Making, and How Can It Help Patients?

Drugs.com

14, 2023 (American Heart Association News) -- Traditionally, many decisions about medical treatment were left up to doctors: They decided, and patients agreed. MONDAY, Aug. Today, health care professionals are embracing the idea of shared.

Doctors 246